Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma

NCT02474563 · clinicaltrials.gov ↗

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: Melphalan
DRUG: Prednisone

Sponsor

Janssen Korea, Ltd., Korea